Thaís T.O. Santos

Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis

Daniel Dias, Patrícia A.F. Ribeiro, Vívian T. Martins et al. · Cellular Immunology · 2017 · 47 citations

Parasitic Protozoa, Leishmania Infantum, Pathogenesis +7

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias et al. · npj Vaccines · 2020 · 47 citations · Full text

Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis

Áquila S.B. Portela, Lourena E. Costa, Beatriz C.S. Salles et al. · Immunobiology · 2017 · 40 citations

Inflammation, Immune Biomarkers, Autoimmune Disease +15

A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection

Mariana C. Duarte, Daniela P. Lage, Vívian T. Martins et al. · Molecular Immunology · 2016 · 33 citations

Vaccination, Leishmania Infantum Infection, Vaccine Development +10

An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans

Ana Maria Ravena Severino Carvalho, Lourena E. Costa, Beatriz C.S. Salles et al. · Cellular Immunology · 2017 · 30 citations

Parasitic Disease, Tegumentary Leishmaniasis, Leishmania Hypothetical Protein +9